Related references
Note: Only part of the references are listed.Pattern of metastatic spread in triple-negative breast cancer
Rebecca Dent et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Risk Factors for Initial Lung Metastasis from Breast Invasive Ductal Carcinoma in Stages I-III of Operable Patients
Dongwei Gao et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2009)
Immunohistochemically Determined Estrogen Receptor Phenotype Remains Stable in Recurrent and Metastatic Breast Cancer
Carmen Gomez-Fernandez et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast
Krisztina Hanley et al.
HUMAN PATHOLOGY (2008)
Histopathologic factors significantly associated with initial organ-specific metastasis by invasive ductal carcinoma of the breast: a prospective study
Takahiro Hasebe et al.
HUMAN PATHOLOGY (2008)
Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas
Bing Wei et al.
HUMAN PATHOLOGY (2008)
Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer
Jochen Gaedcke et al.
MODERN PATHOLOGY (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma
CA Livasy et al.
MODERN PATHOLOGY (2006)
Breast cancer metastasis to the central nervous system
RJ Weil et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease
J Zidan et al.
BRITISH JOURNAL OF CANCER (2005)
Brain Metastases from breast cancer: Identification of a high-risk group
AJ Evans et al.
CLINICAL ONCOLOGY (2004)
Androgen receptor expression in estrogen receptor-negative breast cancer - Immunohistochemical, clinical, and prognostic associations
SN Agoff et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
Androgen receptors frequently are expressed in breast carcinomas - Potential relevance to new therapeutic strategies
F Moinfar et al.
CANCER (2003)
Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival
KD Miller et al.
ANNALS OF ONCOLOGY (2003)
High incidence of central nervous system involvement in patients with breast cancer treated with epirubicin and docetaxel
H Abali et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2002)
Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites
D Gancberg et al.
ANNALS OF ONCOLOGY (2002)
HER2 status in patients with breast carcinoma is not modified selectively by preoperative chemotherapy and is stable during the metastatic process
A Vincent-Salomon et al.
CANCER (2002)
Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR:: evidence that MYC is an AR-regulated gene
I Bièche et al.
CARCINOGENESIS (2001)
Identifying breast cancer patients at high risk for bone metastases
M Colleoni et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
